Article Details

FDA approves atezolizumab–lurbinectedin for ES-SCLC

Retrieved on: 2025-10-05 05:52:34

Tags for this article:

Click the tags to see associated articles and topics

FDA approves atezolizumab–lurbinectedin for ES-SCLC. View article details on hiswai:

Excerpt

Together, the combination targets both the tumour cells directly and the immune system, providing a complementary mechanism to delay disease ...

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo